Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanorobot with Hidden Weapon Precisely Targets and Kills Cancer Cells

By HospiMedica International staff writers
Posted on 03 Jul 2024

Researchers have developed nanorobots capable of eliminating cancer cells in mice, utilizing a weapon concealed within a nanostructure that only activates within the tumor environment, thus protecting healthy cells. More...

The research group at Karolinska Institutet (Solna, Sweden) previously developed structures that arrange what are known as death receptors on cell surfaces, leading to cell death. These structures feature six peptides aligned in a hexagonal formation, forming a deadly nanopattern. If deployed as a medication, this configuration would nonspecifically destroy cells throughout the body, which is undesirable. To circumvent this issue, the team encapsulated the lethal mechanism within a nanostructure made of DNA. This method, known as DNA origami, involves using DNA to craft nanoscale structures and has been the team’s research focus for several years. In the new study published in the journal Nature Nanotechnology, the researchers utilized this approach to develop a 'kill switch' that activates under specific conditions.

The researchers have cleverly concealed the lethal weapon so that it reveals itself only within the environment found in and around a solid tumor, effectively creating a nanorobot designed to selectively attack and destroy cancer cells. This activation is triggered by the acidic environment typically present around cancer cells, characterized by a low pH level. Laboratory tests in test tubes showed that at a normal pH of 7.4, the peptide weapon remains hidden within the nanostructure, but it becomes highly destructive when the pH level drops to 6.5. Following this, the team injected these nanorobots into mice with breast cancer tumors, which led to a significant 70% decrease in tumor growth compared to mice treated with a non-active version of the nanorobot.

“We now need to investigate whether this works in more advanced cancer models that more closely resemble the real human disease,” said the study's first author Yang Wang, a researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet. “We also need to find out what side effects the method has before it can be tested on humans.”

Related Links:
Karolinska Institute


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.